Meeder Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.7K | Buy |
92
+55
| +149% | +$13.7K | ﹤0.01% | 564 |
|
|
2025
Q4 | $8.91K | Buy |
37
+2
| +6% | +$511 | ﹤0.01% | 696 |
|
|
2025
Q3 | $9.58K | Hold |
35
| – | – | ﹤0.01% | 552 |
|
|
2025
Q2 | $9.03K | Buy |
35
+2
| +6% | +$477 | ﹤0.01% | 638 |
|
|
2025
Q1 | $7.39K | Sell |
33
-11
| -25% | -$2.57K | ﹤0.01% | 699 |
|
|
2024
Q4 | $10.1K | Sell |
44
-3,173
| -99% | -$764K | ﹤0.01% | 696 |
|
|
2024
Q3 | $785K | Buy |
3,217
+3,174
| +7,381% | +$709K | 0.05% | 152 |
|
|
2024
Q2 | $8.23K | Sell |
43
-4
| -9% | -$812 | ﹤0.01% | 692 |
|
|
2024
Q1 | $9.31K | Buy |
+47
| New | +$8.61K | ﹤0.01% | 561 |
|
|
2023
Q1 | – | Sell |
-322
| Closed | -$67K | – | 787 |
|
|
2022
Q4 | $67K | Sell |
322
-1,977
| -86% | -$434K | 0.01% | 503 |
|
|
2022
Q3 | $502K | Buy |
2,299
+930
| +68% | +$212K | 0.03% | 381 |
|
|
2022
Q2 | $287K | Buy |
1,369
+200
| +17% | +$42.6K | 0.02% | 522 |
|
|
2022
Q1 | $284K | Buy |
+1,169
| New | +$283K | 0.01% | 583 |
|
|
2021
Q4 | – | Sell |
-1,194
| Closed | -$316K | – | 2092 |
|
|
2021
Q3 | $316K | Buy |
1,194
+606
| +103% | +$166K | 0.02% | 614 |
|
|
2021
Q2 | $145K | Sell |
588
-830
| -59% | -$174K | 0.01% | 808 |
|
|
2021
Q1 | $275K | Buy |
1,418
+742
| +110% | +$149K | 0.01% | 654 |
|
|
2020
Q4 | $144K | Sell |
676
-5,852
| -90% | -$1.17M | 0.03% | 359 |
|
|
2020
Q3 | $1.12M | Sell |
6,528
-3,732
| -36% | -$689K | 0.07% | 221 |
|
|
2020
Q2 | $1.97M | Buy |
10,260
+489
| +5% | +$80K | 0.13% | 144 |
|
|
2020
Q1 | $1.44M | Buy |
9,771
+2,857
| +41% | +$455K | 0.11% | 152 |
|
|
2019
Q4 | $1.07M | Buy |
6,914
+4,950
| +252% | +$713K | 0.07% | 245 |
|
|
2019
Q3 | $265K | Hold |
1,964
| – | – | 0.02% | 539 |
|
|
2019
Q2 | $241K | Sell |
1,964
-15,177
| -89% | -$1.68M | 0.02% | 542 |
|
|
2019
Q1 | $1.78M | Buy |
17,141
+16,937
| +8,302% | +$1.75M | 0.14% | 136 |
|
|
2018
Q4 | $23K | Hold |
204
| – | – | ﹤0.01% | 1032 |
|
|
2018
Q3 | $24K | Sell |
204
-1,058
| -84% | -$116K | ﹤0.01% | 983 |
|
|
2018
Q2 | $131K | Buy |
+1,262
| New | +$128K | 0.01% | 577 |
|
|
2016
Q4 | – | Sell |
-2,255
| Closed | -$147K | – | 1043 |
|
|
2016
Q3 | $147K | Buy |
+2,255
| New | +$150K | 0.01% | 568 |
|
Other funds holding RMD
VCM
VPM
DAM
Meeder Asset Management's RMD Position: Q1 2026 in Review
Meeder Asset Management increased its ResMed (RMD) stake by 149% in Q1 2026, buying an estimated $13.7K and bringing the position to 92 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #564.
Meeder Asset Management first reported a position in RMD in Q3 2016 and has held it in 28 quarters since. The position peaked at $1.97M in Q2 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Meeder Asset Management held 92 shares of ResMed worth $20.7K as of Q1 2026.
- Meeder Asset Management bought 55 ResMed shares in Q1 2026, an estimated $13.7K.
- ResMed made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #564 holding.
- Meeder Asset Management first reported a position in ResMed in Q3 2016 and has held it in 28 quarters since.
- Meeder Asset Management's ResMed position peaked at $1.97M in Q2 2020.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.